These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29678923)

  • 1. EJE PRIZE 2018: A gut feeling about glucagon.
    Knop FK
    Eur J Endocrinol; 2018 Jun; 178(6):R267-R280. PubMed ID: 29678923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia.
    Suppli MP; Lund A; Bagger JI; Vilsbøll T; Knop FK
    Med Hypotheses; 2016 Jan; 86():100-3. PubMed ID: 26547273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
    Junker AE; Gluud L; Holst JJ; Knop FK; Vilsbøll T
    J Intern Med; 2016 May; 279(5):485-93. PubMed ID: 26728692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of incretin hormones and glucagon in patients with liver disease.
    Junker AE
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
    Wewer Albrechtsen NJ; Færch K; Jensen TM; Witte DR; Pedersen J; Mahendran Y; Jonsson AE; Galsgaard KD; Winther-Sørensen M; Torekov SS; Lauritzen T; Pedersen O; Knop FK; Hansen T; Jørgensen ME; Vistisen D; Holst JJ
    Diabetologia; 2018 Mar; 61(3):671-680. PubMed ID: 29305624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of glucagon secretion by incretins.
    Holst JJ; Christensen M; Lund A; de Heer J; Svendsen B; Kielgast U; Knop FK
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():89-94. PubMed ID: 21824261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of Extrapancreatic Glucagon Secretion in Man.
    Lund A; Bagger JI; Wewer Albrechtsen NJ; Christensen M; Grøndahl M; Hartmann B; Mathiesen ER; Hansen CP; Storkholm JH; van Hall G; Rehfeld JF; Hornburg D; Meissner F; Mann M; Larsen S; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2016 Mar; 65(3):585-97. PubMed ID: 26672094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals.
    Bagger JI; Knop FK; Lund A; Holst JJ; Vilsbøll T
    Diabetologia; 2014 Aug; 57(8):1720-5. PubMed ID: 24879388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Liver-α-Cell Axis and Type 2 Diabetes.
    Wewer Albrechtsen NJ; Pedersen J; Galsgaard KD; Winther-Sørensen M; Suppli MP; Janah L; Gromada J; Vilstrup H; Knop FK; Holst JJ
    Endocr Rev; 2019 Oct; 40(5):1353-1366. PubMed ID: 30920583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
    Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.
    Orskov C; Jeppesen J; Madsbad S; Holst JJ
    J Clin Invest; 1991 Feb; 87(2):415-23. PubMed ID: 1991827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels.
    Gar C; Haschka SJ; Kern-Matschilles S; Rauch B; Sacco V; Prehn C; Adamski J; Seissler J; Wewer Albrechtsen NJ; Holst JJ; Lechner A
    Diabetologia; 2021 Mar; 64(3):512-520. PubMed ID: 33275161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dysregulated glucagon secretion in type 2 diabetes.
    D'Alessio D
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.